Molecular biomarker for cytoreductive nephrectomy?

Tobias Klatte, MD, PhD, FEBU, FRCS(Ed)
Consultant Urological Surgeon, Royal Bournemouth Hospital Visiting Researcher, University of Cambridge Honorary Lecturer, University of Edinburgh asks the question “Molecular biomarker for cytoreductive nephrectomy?” at the Kidney Cancer International Symposium 2019 in Dubrovnik, Croatia